Cui Xiangmin's Form 4 filing
BeyondSpring Inc. (BYSI) · filed Sep 24, 2025
- Accession no.
- 0001231919-25-000244
- Filed
- Sep 24, 2025, 6:49 PM ET
- Trade date
- Sep 22-24, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $20.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cui XiangminCIK 0001487815 | 10% Owner |
| Decheng Capital China Life Sciences USD Fund II, L.P.CIK 0001650291 | 10% Owner |
| Decheng Capital China Life Sciences USD Fund III, L.P.CIK 0001736814 | 10% Owner |
| Decheng Capital Management III (Cayman), LLCCIK 0001747821 | 10% Owner |
| Decheng Capital Global Healthcare Fund (Master), LPCIK 0001949026 | 10% Owner |
| Decheng Capital Global Healthcare GP, LLCCIK 0001949027 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | Ordinary Shares | SSaleDisposed | −5,410 | $1.83F1 | −$9,900.3 | 1,853,923 | Indirect | |
| Sep 23, 2025 | Ordinary Shares | SSaleDisposed | −4,106 | $1.72F3 | −$7,062.32 | 1,849,817 | Indirect | |
| Sep 24, 2025 | Ordinary Shares | SSaleDisposed | −2,256 | $1.68F4 | −$3,790.08 | 1,847,561 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.67 to $1.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.